OBJECTIVE. The purpose of this study was to evaluate the repeatability of liver mean standardized uptake value normalized to lean body mass (SULmean) in the same patients at different time points within the right lobe of the liver at (18)F-FDG PET/CT, in a clinical setting. MATERIALS AND METHODS. Two PET/CT studies performed on two different dates from each of 130 patients who had normal livers according to structural imaging were included in this reader study. The mean (± SD) length of time between the studies was 235 ± 192 days. SULmean was measured with a 30-mm diameter spherical volume of interest (VOI) placed within the right lobe of the liver (above, below, and at the level of the main portal vein) by two expert readers. ANOVA, intraclass correlation coefficient (ICC), and Bland-Altman analysis were performed. RESULTS. The ICC for the first and second set of studies varied between 0.487 and 0.535 for reader 1 and between 0.472 and 0.545 for reader 2. The mean percentage variation for SULmean between the two time scans for the VOIs placed above, below, and at the level of the main portal vein were 3.55% ± 23.19%, 4.65% ± 23.87%, and 4.30% ± 23.03%, respectively, for reader 1 and 4.49% ± 23.23%, 4.33% ± 23.74%, and 4.48% ± 23.01%, respectively, for reader 2. Using 95% CI, the reference range for intrapatient variations between the studies in liver SULmean was -0.5 to 0.60. CONCLUSION. There is only fair repeatability of liver SULmean measured between two time points in the same patient in a clinical setting. Scan-to-scan intrapatient variation in absolute liver SULmean was -0.5 to 0.60.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870645 | PMC |
| http://dx.doi.org/10.2214/AJR.14.12719 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prediction of Early-stage Liver Fibrosis Using FDG-PET/CT.
Anticancer Res
September 2023
Department of Radiology, Graduate School of Medical Science, University of the Ryukyus, Okinawa, Japan.
Background/aim: F-fluorodeoxyglucose (FDG) is known to accumulate in the liver. We investigated whether accumulation of FDG was correlated with the degree of liver fibrosis and the grade of necro-inflammatory activity.
Patients And Methods: This retrospective study included 35 patients who underwent FDG-positron emission tomography (PET)/computed tomography (CT) before liver surgery.
Impact of patient characteristic factors on the dynamics of liver glucose metabolism: Evaluation of multiparametric imaging with dynamic whole-body F-fluorodeoxyglucose-positron emission tomography.
Diabetes Obes Metab
December 2023
Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
Article Synopsis
- The study aimed to evaluate how different patient characteristics affect liver glucose metabolism using advanced imaging techniques.
- The research involved 540 patients and analyzed three key metrics of liver glucose metabolism through a model-based imaging method, correlating these metrics with factors like age, sex, and the presence of diabetes.
- Results indicated significant relationships between these patient characteristics and liver metabolism metrics, highlighting the potential for using multiparametric FDG-PET imaging in clinical assessments of liver glucose dynamics.
Glucose uptake and distribution across the human skeleton using state-of-the-art total-body PET/CT.
Bone Res
July 2023
Department of PET-CT, the First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital Affiliated with Shandong University, Jinan, 250014, China.
A growing number of studies have demonstrated that the skeleton is an endocrine organ that is involved in glucose metabolism and plays a significant role in human glucose homeostasis. However, there is still a limited understanding of the in vivo glucose uptake and distribution across the human skeleton. To address this issue, we aimed to elucidate the detailed profile of glucose uptake across the skeleton using a total-body positron emission tomography (PET) scanner.
View Article and Find Full Text PDFArtificial intelligence-based PET denoising could allow a two-fold reduction in [F]FDG PET acquisition time in digital PET/CT.
Eur J Nucl Med Mol Imaging
September 2022
Department of Nuclear Medicine, Baclesse Cancer Center, 3 Avenue Général Harris, 14076, Caen, France.
Purpose: We investigated whether artificial intelligence (AI)-based denoising halves PET acquisition time in digital PET/CT.
Methods: One hundred ninety-five patients referred for [F]FDG PET/CT were prospectively included. Body PET acquisitions were performed in list mode.
Predicting the Recurrence of Hepatocellular Carcinoma after Primary Living Donor Liver Transplantation Using Metabolic Parameters Obtained from F-FDG PET/CT.
J Clin Med
January 2022
Department of Nuclear Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Korea.
This study evaluated the prognostic value of metabolic parameters based on the standardized uptake value (SUV) normalized by total body weight (bwSUV) and by lean body mass (SUL) measured on F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for predicting tumor recurrence after primary living donor liver transplantation (LDLT) in patients with hepatocellular carcinoma (HCC) without transplantation locoregional therapy. This retrospective study enrolled 49 patients with HCC. The maximum tumor bwSUV (T-bwSUVmax) and SUL (T-SULmax) were measured on PET.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!